Nerve Agents - 21/08/11
Doi : 10.1016/j.ncl.2004.12.013
Jonathan Newmark, MD, COL, MC, USAR a, b, c, ⁎ 
a United States Army Medical Research Institute of Chemical Defense, Aberdeen Proving Ground, MD, USA
b Office of the Assistant Secretary for Public Health Emergency Preparedness, United States Department of Health and Human Services, Washington, DC, USA
c F. Edward Hebert School of Medicine, Uniformed Services University of the Health Sciences, Bethesda, MD, USA
CDR, United States Army Medical Research Institute of Chemical Defense, Attn: MCMR-UV-ZM, 3100 Ricketts Point Road, Aberdeen Proving Ground, MD 21010-5400.Plan
| The opinions expressed herein are those solely of the author and not necessarily those of the Department of Defense, the Department of the Army, or of the Army Medical Research and Materiel Command. This article is an update of previously published material, [Newmark J. Nerve agents: pathophysiology and therapy of poisoning. Semin Neurol 2004;24:185–96]; which appears here courtesy of the permission of the editor, Robert Pascuzzi, MD. |
© 2005
Elsevier Inc. Tous droits réservés.
Vol 23 - N° 2
P. 623-641 - mai 2005 Retour au numéro
Article précédent
- Neurobiological Weapons
- Peter J. Osterbauer, Michael R. Dobbs
- Index
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?